[
  {
    "ts": null,
    "headline": "Charles River (CRL) International Revenue Performance Explored",
    "summary": "Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=d9239df23c0ed09222640aca9eea3c1e5300b25f427c1702bae70fc1d5114aa5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763388908,
      "headline": "Charles River (CRL) International Revenue Performance Explored",
      "id": 137506869,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=d9239df23c0ed09222640aca9eea3c1e5300b25f427c1702bae70fc1d5114aa5"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Laboratories to Present at Jefferies Global Healthcare Conference",
    "summary": "WILMINGTON, Mass., November 17, 2025--Charles River Laboratories to Present at Jefferies Global Healthcare Conference",
    "url": "https://finnhub.io/api/news?id=4c99396ec86f0f4f679f9dd281021091b6f5f341c4e0e91ddde27c4d7303bd27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763384400,
      "headline": "Charles River Laboratories to Present at Jefferies Global Healthcare Conference",
      "id": 137504396,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "WILMINGTON, Mass., November 17, 2025--Charles River Laboratories to Present at Jefferies Global Healthcare Conference",
      "url": "https://finnhub.io/api/news?id=4c99396ec86f0f4f679f9dd281021091b6f5f341c4e0e91ddde27c4d7303bd27"
    }
  },
  {
    "ts": null,
    "headline": "Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest",
    "summary": "Looking back on drug development inputs & services stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.",
    "url": "https://finnhub.io/api/news?id=8758a28696e49877105c7ba74ec71d2dbd0eb179a2ca8173f3452182ef5010da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763350632,
      "headline": "Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest",
      "id": 137506870,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Looking back on drug development inputs & services stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.",
      "url": "https://finnhub.io/api/news?id=8758a28696e49877105c7ba74ec71d2dbd0eb179a2ca8173f3452182ef5010da"
    }
  }
]